Pharma Bio Serv Stock Performance
| PBSV Stock | USD 0.59 0.01 1.72% |
Pharma-Bio Serv has a performance score of 2 on a scale of 0 to 100. The company holds a Beta of -0.52, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Pharma-Bio Serv are expected to decrease at a much lower rate. During the bear market, Pharma-Bio Serv is likely to outperform the market. Pharma Bio Serv right now holds a risk of 4.35%. Please check Pharma Bio Serv jensen alpha and the relationship between the potential upside and price action indicator , to decide if Pharma Bio Serv will be following its historical price patterns.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Pharma Bio Serv are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Pharma-Bio Serv may actually be approaching a critical reversion point that can send shares even higher in March 2026. ...more
| Begin Period Cash Flow | 17.5 M | |
| Free Cash Flow | 573.2 K |
Pharma-Bio |
Pharma-Bio Serv Relative Risk vs. Return Landscape
If you would invest 58.00 in Pharma Bio Serv on November 28, 2025 and sell it today you would earn a total of 1.00 from holding Pharma Bio Serv or generate 1.72% return on investment over 90 days. Pharma Bio Serv is currently generating 0.1199% in daily expected returns and assumes 4.3459% risk (volatility on return distribution) over the 90 days horizon. In different words, 39% of otc stocks are less volatile than Pharma-Bio, and 98% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Pharma-Bio Serv Target Price Odds to finish over Current Price
The tendency of Pharma-Bio OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.59 | 90 days | 0.59 | about 15.95 |
Based on a normal probability distribution, the odds of Pharma-Bio Serv to move above the current price in 90 days from now is about 15.95 (This Pharma Bio Serv probability density function shows the probability of Pharma-Bio OTC Stock to fall within a particular range of prices over 90 days) .
Pharma-Bio Serv Price Density |
| Price |
Predictive Modules for Pharma-Bio Serv
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Pharma Bio Serv. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pharma-Bio Serv's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Pharma-Bio Serv Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Pharma-Bio Serv is not an exception. The market had few large corrections towards the Pharma-Bio Serv's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Pharma Bio Serv, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Pharma-Bio Serv within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.26 | |
β | Beta against Dow Jones | -0.52 | |
σ | Overall volatility | 0.03 | |
Ir | Information ratio | 0.03 |
Pharma-Bio Serv Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Pharma-Bio Serv for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Pharma Bio Serv can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Pharma Bio Serv has some characteristics of a very speculative penny stock | |
| Pharma Bio Serv had very high historical volatility over the last 90 days | |
| About 65.0% of the company outstanding shares are owned by corporate insiders |
Pharma-Bio Serv Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Pharma-Bio OTC Stock often depends not only on the future outlook of the current and potential Pharma-Bio Serv's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pharma-Bio Serv's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 22.9 M | |
| Dividends Paid | 3.4 M | |
| Forward Annual Dividend Rate | 0.07 | |
| Shares Float | 12.3 M |
Pharma-Bio Serv Fundamentals Growth
Pharma-Bio OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Pharma-Bio Serv, and Pharma-Bio Serv fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Pharma-Bio OTC Stock performance.
| Return On Equity | 0.0568 | |||
| Return On Asset | 0.033 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 4.87 M | |||
| Shares Outstanding | 22.95 M | |||
| Price To Earning | 10.00 X | |||
| Price To Book | 1.15 X | |||
| Price To Sales | 0.90 X | |||
| Revenue | 19.4 M | |||
| EBITDA | 1.23 M | |||
| Cash And Equivalents | 14.24 M | |||
| Cash Per Share | 0.62 X | |||
| Total Debt | 520.77 K | |||
| Debt To Equity | 0.03 % | |||
| Book Value Per Share | 0.72 X | |||
| Cash Flow From Operations | 592.46 K | |||
| Earnings Per Share | 0.04 X | |||
| Total Asset | 20.65 M | |||
| Retained Earnings | 20.5 M | |||
| Current Asset | 22.27 M | |||
| Current Liabilities | 1.67 M | |||
About Pharma-Bio Serv Performance
Evaluating Pharma-Bio Serv's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Pharma-Bio Serv has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Pharma-Bio Serv has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico. Pharma Bio operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 190 people.Things to note about Pharma Bio Serv performance evaluation
Checking the ongoing alerts about Pharma-Bio Serv for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Pharma Bio Serv help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Pharma Bio Serv has some characteristics of a very speculative penny stock | |
| Pharma Bio Serv had very high historical volatility over the last 90 days | |
| About 65.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Pharma-Bio Serv's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pharma-Bio Serv's stock is overvalued or undervalued compared to its peers.
- Examining Pharma-Bio Serv's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Pharma-Bio Serv's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pharma-Bio Serv's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Pharma-Bio Serv's otc stock. These opinions can provide insight into Pharma-Bio Serv's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Pharma-Bio OTC Stock Analysis
When running Pharma-Bio Serv's price analysis, check to measure Pharma-Bio Serv's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma-Bio Serv is operating at the current time. Most of Pharma-Bio Serv's value examination focuses on studying past and present price action to predict the probability of Pharma-Bio Serv's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma-Bio Serv's price. Additionally, you may evaluate how the addition of Pharma-Bio Serv to your portfolios can decrease your overall portfolio volatility.